Literature DB >> 1828835

Species differences in percutaneous absorption of nicorandil.

K Sato1, K Sugibayashi, Y Morimoto.   

Abstract

The species difference in skin permeability, Kp, of nicorandil was determined by using excised skin samples from hairless mouse, hairless rat, guinea-pig, dog, pig, and human. The Kp value of nicorandil in hairless mice was the greatest among the six species, and those in pigs and humans were in good agreement. To clarify the reasons for the species difference, various skin characteristics in each species were measured. It was suggested that the difference of skin surface lipids in each species affected the partitioning of nicorandil from vehicle to stratum corneum, and that such a difference would be a main factor for the species difference in nicorandil permeability. Since pig and human skins had similar surface lipids, barrier thickness, and morphological aspects, percutaneous absorption studies using excised pig skin samples would be useful for the estimation of in vitro human skin permeation behavior.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828835     DOI: 10.1002/jps.2600800203

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

1.  Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.

Authors:  Syunsuke Yamamoto; Masatoshi Karashima; Noriyasu Sano; Chiharu Fukushi; Kimio Tohyama; Yuta Arai; Hideki Hirabayashi; Nobuyuki Amano
Journal:  Pharm Res       Date:  2017-08-21       Impact factor: 4.200

2.  Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin.

Authors:  Nuntakan Suwanpidokkul; Phensri Thongnopnua; Kaisri Umprayn
Journal:  AAPS PharmSciTech       Date:  2004-08-18       Impact factor: 3.246

3.  Percutaneous absorption of sunscreens through micro-yucatan pig skin in vitro.

Authors:  V K Gupta; J L Zatz; M Rerek
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

4.  Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light.

Authors:  Manuela Buonanno; Brian Ponnaiya; David Welch; Milda Stanislauskas; Gerhard Randers-Pehrson; Lubomir Smilenov; Franklin D Lowy; David M Owens; David J Brenner
Journal:  Radiat Res       Date:  2017-02-22       Impact factor: 2.841

5.  Tumor necrosis factor-α, monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 increase during the development of a 2,4-dinitrofluorobenzene-induced immediate-type dermatitis in rats.

Authors:  Guangchen Sun; Yaqin Wang; Bo Yin; Lingjin Zhu; Yingqin Liu
Journal:  Inflamm Res       Date:  2013-03-26       Impact factor: 4.575

6.  Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers based on a two-layer skin model.

Authors:  D Kobayashi; T Matsuzawa; K Sugibayashi; Y Morimoto; M Kimura
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

7.  Effect of hydroxyl groups and rigid structure in 1,4-cyclohexanediol on percutaneous absorption of metronidazole.

Authors:  Yan Zhang; Fengping Tan; Weipu Jia; Nan Li; Jerry Zhang
Journal:  AAPS PharmSciTech       Date:  2014-05-13       Impact factor: 3.246

8.  Utility of MTT assay in three-dimensional cultured human skin model as an alternative for draize skin irritation test: approach using diffusion law of irritant in skin and toxicokinetics-toxicodynamics correlation.

Authors:  Tetsuya Watanabe; Tetsuya Hasegawa; Hidekazu Takahashi; Takuya Ishibashi; Hiroshi Itagaki; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

9.  Predicting topical drug clearance from the skin.

Authors:  Maria Alice Maciel Tabosa; Magdalena Hoppel; Annette L Bunge; Richard H Guy; M Begoña Delgado-Charro
Journal:  Drug Deliv Transl Res       Date:  2020-11-08       Impact factor: 4.617

10.  207-nm UV Light-A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. II: In-Vivo Safety Studies.

Authors:  Manuela Buonanno; Milda Stanislauskas; Brian Ponnaiya; Alan W Bigelow; Gerhard Randers-Pehrson; Yanping Xu; Igor Shuryak; Lubomir Smilenov; David M Owens; David J Brenner
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.